U.S. markets close in 2 hours 9 minutes
  • S&P 500

    -34.58 (-0.83%)
  • Dow 30

    -304.14 (-0.89%)
  • Nasdaq

    -156.10 (-1.12%)
  • Russell 2000

    -55.03 (-2.47%)
  • Crude Oil

    -0.83 (-1.31%)
  • Gold

    +8.00 (+0.45%)
  • Silver

    -0.01 (-0.03%)

    -0.0010 (-0.08%)
  • 10-Yr Bond

    -0.0440 (-2.75%)

    -0.0049 (-0.35%)

    -0.0110 (-0.01%)

    +970.82 (+1.77%)
  • CMC Crypto 200

    +37.63 (+3.05%)
  • FTSE 100

    -140.21 (-2.00%)
  • Nikkei 225

    -584.99 (-1.97%)

FusionPharm Completes First Order from GrowLife

DENVER, CO, August 8, 2013 - (Accesswire) - FusionPharm, Inc. (FSPM), the developer of the patent pending PharmPods(TM) hydroponic cultivation system (www.pharmpods.com), today announced that it has completed its first purchase from GrowLife, Inc. (PHOT), under the recently announced collaboration agreement.

"Our collaboration with GrowLife allows us to see cost reductions on our equipment of approximately 11% and is also streamlining our warranty process, both of which improve overall profitability," stated FusionPharm CEO, Scott Dittman. "In addition, we now have a partner with product expertise that we can rely on to provide advice as new products become available. GrowLife also gives us an invaluable nationwide sales presence to aid in the distribution of our PharmPod(TM) High Intensity line of commercial cultivation systems."

"FusionPharm not only represents a great customer and revenue increase for GrowLife, Inc, but the PharmPod System is the clear industry leader for modular turn-key commercial grows," added Sterling Scott, CEO of GrowLife. "In addition, feedback from FusionPharm's existing customer base will enhance our product research and review function on our industry leading hydroponic product websites, www.greners.com and www.58hydro.com."

About FusionPharm, Inc.
FusionPharm, Inc. (FSPM) (www.fusionpharminc.com) was organized to capitalize on opportunities present in the rapidly growing vertical farming and cannabis industries. FusionPharm's primary focus is the development and deployment of the patent pending PharmPods(TM) advanced hydroponic commercial cultivation systems. PharmPods are constructed from standard ISO steel shipping containers that are repurposed for use in indoor controlled environment agriculture. Modular, stackable, cost competitive and financeable, PharmPods have become the industry leader for professional, commercial scale indoor plant cultivation.

About GrowLife, Inc.
GrowLife, Inc. (PHOT) (www.growlifeinc.com) is a company with core holdings in innovative technology-based products and services for the indoor gardening industry and specialty markets. These brands include Greners.com, the online hydroponics superstore (www.greners.com), Phototron, producer of hydroponic grow containers, which are designed to grow vegetables, herbs, flowers and fruits in any environment (www.phototron.com) as well as bricks and mortar retailers Urban Garden, Rocky Mountain Hydroponics and Evergreen Garden Center (www.rmgardener.com).

Except for any historical information contained herein, the matters discussed in this press release contain forward-looking statements that involve risks and uncertainties, including those described in the Company's Securities and Exchange Commission reports and filings. Certain statements contained in this release that are not historical facts constitute forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, and are intended to be covered by the safe harbors created by that Act. Reliance should not be placed on forward-looking statements because they involve unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied. Forward-looking statements may be identified by words such as estimates, anticipates, projects, plans, expects, intends, believes, should and similar expressions and by the context in which they are used. Such statements are based upon current expectations of the Company and speak only as of the date made. The Company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which they are made.


Contact: FusionPharm, Inc.

SOURCE FusionPharm, Inc.